Mark A. Ware, McGill University
Canada is poised to legalize and regulate
the non-medical use of cannabis, the first G7 country to
do so. This policy shift will touch many aspects of Canadian
society, will create an entirely new industry, and will
attract international interest. Developing and implementing
a framework for cannabis regulation has raised many questions
about what we know, what we do not know, and what we need
to know regarding this popular and often misunderstood drug.
This session will outline some of the key themes and influences
that have shaped this transformation, and identify those
who will play a role in shaping the impact of this policy
on Canadian society.
Dr. Mark Ware is a family physician and Associate Professor
in Family Medicine and Anesthesia at McGill University.
He is the Director of Clinical Research of the Alan Edwards
Pain Management Unit at the McGill University Health Centre
and Executive Director of the non-profit Canadian Consortium
for the Investigation of Cannabinoids. His research interests
include the safety and effectiveness of medicines derived
from cannabis and the therapeutic effectiveness of complementary
strategies to manage pain. He has served as an advisor to
the Canadian government since 2001, most recently as vice
Chair of the Federal Task Force on the legalization and
regulation of cannabis in Canada.
The presentation will
be in English.
Organized by: The Partnership Group for Science
and Engineering (PAGSE).
Supported by: CANARIE inc. and Natural Sciences and Engineering
Research Council (NSERC) and many
The Speaker of the Senate
The Speaker of the House of Commons
Date: Thursday, April 26, 2018, 7:30 am - 8:30 am (Hot breakfast
is ready by 7am)
Location: Parliamentary Dining Room, Centre
Cost: No charge to Members of the House of Commons, Senators
and Media. All others $25. Payment must be made in advance
by credit card. No refunds for cancellations after April
Contact information: Donna Boag, email@example.com,